Dr. Chris Chen, MD
Claim this profileStanford Cancer Center
Studies Melanoma
Studies Non-Small Cell Lung Cancer
2 reported clinical trials
4 drugs studied
Area of expertise
1Melanoma
Stage IV
BRAF
NRAS
2Non-Small Cell Lung Cancer
Stage IV
BRAF
NRAS
Affiliated Hospitals
More about Chris Chen, MD
Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Chris Chen, MD has experience with
- KIN-2787
- Cemiplimab
- E-602
- Pembrolizumab
Breakdown of trials Chris Chen, MD has run
Melanoma
Non-Small Cell Lung Cancer
Stomach Cancer
Head and Neck Cancers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Chris Chen, MD specialize in?
Chris Chen, MD focuses on Melanoma and Non-Small Cell Lung Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are BRAF.
Is Chris Chen, MD currently recruiting for clinical trials?
No, Chris Chen, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Chris Chen, MD has studied deeply?
Yes, Chris Chen, MD has studied treatments such as KIN-2787, Cemiplimab, E-602.
What is the best way to schedule an appointment with Chris Chen, MD?
Apply for one of the trials that Chris Chen, MD is conducting.
What is the office address of Chris Chen, MD?
The office of Chris Chen, MD is located at: Stanford Cancer Center, Stanford, California 94305 United States. This is the address for their practice at the Stanford Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.